Clinical Trial Results for Antithrombin Deficiency

2 Clinical Trials for Antithrombin Deficiency

Focus your search

      RECRUITING
      Efficacy of Atenativ in Patients With Congenital Antithrombin Deficiency Undergoing Surgery or Delivery
      Description

      The goal of this study is to assess the incidence of the composite of thrombotic events (TEs) and thromboembolic events (TEEs) in patients with congenital antithrombin deficiency under when they receive Atenativ for surgical procedures or parturition.

      Conditions
      Congenital Antithrombin Deficiency
      Talk to us
      RECRUITING
      Phase 3 Study on the Efficacy and Safety of Human Plasma Derived Antithrombin (Atenativ) in Heparin-Resistant Patients Scheduled to Undergo Cardiac Surgery Necessitating Cardiopulmonary Bypass
      Description

      The primary objective of this study is to evaluate the efficacy of two different doses of Atenativ, versus placebo, in restoring and maintaining heparin responsiveness in adult patients undergoing cardiac surgery necessitating cardiopulmonary bypass (CPB)

      Conditions
      Acquired Antithrombin Deficiency
      Talk to us